GENERAL16 Sept 2026
Godavari Biorefineries share price rallies 13% after Chinese patent grant | Do you own? | Stock Market News
Godavari Biorefineries shares rose up to 13% to ₹258.87 on the NSE on Wednesday, after the company got a Chinese patent for compounds used in viral infection medicines. This matters to shareholders and anyone tracking the stock. The patent is a positive step, but the company still posted a wider Q1 FY27 loss of ₹19.3 crore. Check your holdings before reacting.
Key Statutory Highlights
- Godavari Biorefineries received a patent from the Chinese Patent Office for compounds that inhibit V-ATPase activity in cells, used in making medicines to treat viral infections.
- The Chinese patent was granted on September 15, 2026, and the application for it was filed on May 10, 2021.
- The company reported a wider loss of ₹19.3 crore in Q1 FY27 compared with ₹16 crore a year earlier, even as total income rose to ₹559.9 crore.
Actionable Advice for Taxpayers / Founders:If you hold or plan to buy this stock, review it against your own goals and consider checking with a financial adviser, since a patent grant alone does not promise future profits.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: